… In the European Lacidipine Study on Atherosclerosis (ELSA), lacidipine, … that lacidipine
may also be efficacious in the prevention or treatment of arterial stiffness over and above its BP-…

Lacidipine (LAC) is a calcium antagonist used in the treatment of hypertension. It is a lipophilic
drug containing dihydropyridine ring that is responsible for the activity. This review article …

… The aim of this review article is to provide utmost existing analytical methods for analysis
of dihydropyridines based calcium channel blockers for estimation of Amlodipine, Lacidipine, …

… resistant hypertension. To obtain more information on this issue we need the data of the
European Lacidipine … , double-blind trial on hypertensive patients comparing the effects a 4-year …

… issue of HTN treatment and need to bring into human trial. Compritol 888 ATO, oleic acid,
and Lutrol F68 have been used to make a lacidipine-loaded nano lipid carrier using an …

… events in patients with isolated systolic hypertension, as well as in elderly and high-risk
patients. Accordingly, CCBs are indicated for hypertension in elderly patients, isolated systolic …

… Lacidipine (LAC) is a calcium channel blocker … It has been used for the treatment of
hypertension, arteriosclerosis, and also exhibited antioxidant activity. It decreases blood pressure by …

… The objective of this research study was to fabricate and investigate lacidipine-loaded …
increasing the bioavailability and efficiency of lacidipine for the treatment of hypertension. …

… with essential hypertension (17). Thus, we hypothesized that Lacidipine may attenuate …
in vivo effects of Lacidipine on CXCR7/P38/C/EBP-β were assessed by using spontaneous …

… 2015 and June 2016 in our Hypertension Centre, and gave informed consent for participation
to the study. Local Ethics Committee and institutional review boards approved the protocol. …